# Study Evaluating the Safety and Effects of MN-221 in Subjects With Moderate to Severe Asthma

> **NCT00679263** · PHASE2 · COMPLETED · sponsor: **MediciNova** · enrollment: 17 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** MN-221
- **DRUG:** MN-221
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00679263
- **Lead sponsor:** MediciNova
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-02
- **Primary completion:** 2008-07
- **Final completion:** 2008-07
- **Target enrollment:** 17 (ACTUAL)
- **Last updated:** 2011-12-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00679263

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00679263, "Study Evaluating the Safety and Effects of MN-221 in Subjects With Moderate to Severe Asthma". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00679263. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*